SCHEMBL5997630

SCHEMBL5997630

CCOC(=O)C(CN1C(=O)c2ccc(F)cc2C1=O)C1(C)OCCO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
GABRG2 P18507 3/20 0.40
GABRB3 P28472 3/20 0.40
GABRA5 P31644 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
CYP2C19 P33261 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5997985 0.90 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2PIN1
SCHEMBL5998273 0.90 ALDH1A1 (0.37) ALDH1A1GABRG2GABRB3GABRA5MEN1
SCHEMBL5998692 0.88 ALDH1A1 (0.47) ALDH1A1GABRG2GABRB3GABRA5MEN1
SCHEMBL5996844 0.88 GABRA1 (0.39) ALDH1A1GABRG2GABRB3GABRA5MEN1
SCHEMBL5998501 0.86 CA9 (0.38) ALDH1A1MEN1KMT2APIN1PIN4
SCHEMBL5997710 0.85 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2MAPK1
SCHEMBL5998695 0.85 PIN1 (0.36) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL5996174 0.83 PIN1 (0.33) ALDH1A1GABRG2GABRB3GABRA5MEN1
SCHEMBL5996055 0.82 HPGD (0.37) ALDH1A1MEN1KMT2ATSHRPIN1
SCHEMBL5997126 0.81 NPC1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094908-B2 Reduction of carbonyl compounds using the carbonyl reductase of Kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-08-22 US disclosed
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus CBR1, CBR3, DCXR ALDH1A1 216/4885GABRG2 1543/4885GABRB3 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.